Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AEterna Zentaris and sanofi-aventis sign agreement for cetrorelix in U.S. market

March 10, 2009

Darifenacin reduces incontinence in overactive bladder patients

March 5, 2009

Anticonvulsants improve urodynamic parameters in rats with NDO

March 4, 2009

Serlopitant effective but less so than tolterodine in overactive bladder

March 3, 2009

Serenity completes phase II clinical trial of CPEX Pharmaceuticals' urology drug

March 2, 2009

Nymox updates the FDA in regard to their phase III program for NX-1207

Feb. 20, 2009

Astellas patent covers EP4 receptor antagonists and their use in treating chronic renal failure

Feb. 13, 2009

Daiichi Sankyo and Kissei to launch Urief tablets for Dysuria in Japan

Feb. 4, 2009

Novel tachykinin NK1 receptor antagonists identified by Merck & Co. researchers

Feb. 3, 2009

Gelnique gel approved by the FDA for overactive bladder

Jan. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...